Skip to main content

Inspection visit

Inspection

ALTERCARE OF MAYFIELD VILLAGE, INCCMS #3662675 citations on this visit
5 citations recorded

Inspector’s narrative

What the inspector wrote

This survey cited 5 deficiencies. The full statement and the facility’s plan of correction follow, verbatim from the federal record.

F 0756 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Some Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record review and interview, the facility failed to ensure the drug regimen of each resident was reviewed at least once a month by a pharmacist and ensure pharmacy recommendations were acted upon. This affected four of five residents reviewed for unnecessary medications (Resident #26, #30, #13, and #33). The total census was 36. Findings include: 1. Record review of Resident #26 revealed she was admitted to the facility on [DATE] and had diagnoses including atrial fibrillation, peripheral vascular disease, heart failure, and cardiomegaly. Record review of pharmacy communications regarding Resident #26 revealed she had a recommendation from pharmacy dated 01/03/23 for a digoxin lab with the next blood draw and every six months thereafter. The recommendation was marked as accepted, however no evidence was found of any digoxin lab draw being done until 09/05/23. Additionally, a recommendation dated 05/01/23 asked for a comprehensive metabolic panel on the next lab draw and to be repeated every 12 months thereafter. The recommendation was marked as accepted, however no evidence was found of a comprehensive metabolic panel for the resident until 09/15/23. Interview with the Interim Director of Nursing on 11/01/23 at 2:00 P.M. confirmed the above findings. 3. Review of the medical record for Resident #13 revealed an admission date of 02/10/23. Diagnoses included aphasia, anxiety disorder, altered mental status, vascular dementia, and other sequela of cerebral infarction. Review of the quarterly Minimum Data Set (MDS) 3.0 assessment for Resident #13 dated 08/14/23 revealed Resident #13 had severely impaired cognition. Medication Regimen reviews with no recommendations were completed for Resident #13 on 04/23, 05/23, and 07/23. Pharmacy recommendations were provided for Resident #13 on 03/07/23, 06/06/23, and 08/02/23. No Medication Regimen reviews or Pharmacy Recommendations were provided for Resident #13 for 09/23 or 10/23. (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 7 Event ID: 366267 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 366267 B. Wing A. Building (X3) DATE SURVEY COMPLETED 11/02/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Altercare of Mayfield Village, Inc 290 North Commons Blvd Mayfield Village, OH 44143 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0756 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Some Interview on 11/02/23 at 2:30 P.M. with Licensed Practical Nurse/Assistant Director of Nursing (LPN/ADON) #600, verified there were no Medication Regimen reviews or Pharmacy Recommendations provided for Resident #13 for 09/23 or 10/23. 4. Review of the medical record for Resident #30 revealed an admission date of 09/30/23. Diagnoses included localized edema, insomnia, glaucoma, gastro-esophageal reflux disease (GERD), muscle weakness, and type II diabetes mellitus. Review of the consultant pharmacist's medication regimen review for Resident #30, dated 10/02/23, revealed to please add an ICD-10 diagnosis to the diagnosis tab of the electronic medication administration record (eMAR) to support the use of the following medications: amitriptyline (antidepressant), Eliquis (anticoagulant), furosemide (diuretic), Januvia (antidiabetic), Lumigan (antiglaucoma), melatonin, insulin degludec (antidiabetic), and pantoprazole (reduces levels of stomach acid). Further review of the consultant pharmacist's recommendation form revealed nothing documented under the area titled Follow Through indicating the recommendation was addressed. Review of the eMAR for October 2023 revealed a blank space under the diagnosis tab for amitriptyline, Eliquis, furosemide, Januvia, Lumigan, melatonin, insulin degludec, and pantoprazole. Interview on 11/02/23 at 8:56 A.M. with Minimum Data Set (MDS) Nurse #608 verified there was diagnosis added to the diagnosis tab of the eMAR for each medication identified. Review of the facility policy titled Medication Regimen Review, dated May 2020 revealed findings and recommendations were to be reported to the Director of Nursing (DON), the attending prescriber, the Medical Director, and if appropriate, the Administrator. Responses were to be made readily available to he consultant pharmacist for follow-up. Under item G: The consultant pharmacist medication regimen review (MRR) and Nursing Documentation Review reports were to be processed as follows and were to be provided in a written or electronic format: 1) Medication Regimen Review Recommendations to Prescriber a.) the consultant pharmacist or facility was to provide the report to the responsible prescriber and DON within seven working days of the review. b.) A copy of the report was to be kept by the facility until the prescriber's signed response was returned. c.) The prescriber was to accept and act upon recommendations or reject and provide an explanation for disagreeing. d.) The facility was to maintain copies of signed reports and make them readily available for the consultant pharmacist for follow-up. 2) Nursing Documentation Review a.) The report was to be provided by the consultant pharmacist within seven working days of the review. b.) A copy of the report was to be kept by the facility until the nurse's response was returned. 2. Review of the medical record for Resident #33 revealed an admission date of 06/15/22 and diagnoses included diabetes, major depression, hypertension, gout, and dementia with behavioral disturbance. Review of lab work in the medical record revealed there was no evidence of a Hemoglobin AIC (HGAIC) (a blood test that reflects an average blood glucose level) or an uric acid level (blood test to check the level of uric acid which often causes gout). Review of pharmacy recommendation dated 11/02/22 revealed Consultant Pharmacist #606 recommended a uric acid level and HGAIC with the next lab draw and repeat both labs in six months. The recommendation had a check mark by the recommendation that Primary Care Physician (PCP) #608 was in agreement with the recommendation but with no date. Review of pharmacy recommendation dated 01/03/23 revealed Consultant Pharmacist #606 recommended (continued on next page) FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 366267 If continuation sheet Page 2 of 7 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 366267 B. Wing A. Building (X3) DATE SURVEY COMPLETED 11/02/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Altercare of Mayfield Village, Inc 290 North Commons Blvd Mayfield Village, OH 44143 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0756 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Some Resident #33's sliding scale be discontinued and to obtain a HGAIC on the next available lab date and repeat the HGAIC in three months. The Interim Director of Nursing (DON) placed a X by the recommendation, check blood sugar twice a day times one week and call if blood sugar below 70 and/or above 250. There was no date on the form. Review of pharmacy recommendation dated 03/07/23 revealed Consultant Pharmacist #606 recommended Resident #33 to have a trial dose reduction of duloxetine (anti-depressant) 20 milligram (mg) by mouth everyday and monitor for symptoms. Nurse Practitioner (NP) #607 checked that he agreed to the trial and signed and dated the recommendation for 09/07/23 (six months after the recommendation was made by the pharmacist). Review of pharmacy recommendation dated 07/03/23 revealed Consultant Pharmacist #606 recommended Resident #33's sliding insulin be discontinued and obtain HGAIC next available lab date and repeat HGAIC in three months. The recommendation had a check mark by the recommendation and was signed by PCP #608 without a date. Review of physician order completed by PCP #608 dated 09/08/23 revealed Resident #33's duloxetine was decreased to 20 mg once a day (per pharmacy recommendation). Interview on 11/01/23 at 2:52 P.M. with the Interim Director of Nursing verified there was no evidence Resident #33 had received an HGAIC or uric acid level despite pharmacy recommendations dated 11/02/22, 01/03/23, and 07/03/23. She also verified Resident #33's pharmacy recommendation dated 03/07/23 for the duloxetine dose reduction was not addressed until 09/07/23. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 366267 If continuation sheet Page 3 of 7 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 366267 B. Wing A. Building (X3) DATE SURVEY COMPLETED 11/02/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Altercare of Mayfield Village, Inc 290 North Commons Blvd Mayfield Village, OH 44143 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760 Ensure that residents are free from significant medication errors. Level of Harm - Minimal harm or potential for actual harm Based on interview, observation, medical record review and policy review the facility did not ensure Resident #48 was free of a significant medication error. This affected one resident (Resident #48) out of one resident reviewed for insulin administration. This had the potential to affect eight residents (Resident #6, #10, #20, #18, #30, #33, #47, and #48) that had orders for insulin. Residents Affected - Few Findings include: Review of medical record for Resident #48 revealed an admission date of 10/13/23 and diagnoses included diabetes, hypertension, and chronic kidney disease. Review of care plan dated 10/16/23 revealed Resident #48 had an alteration in blood glucose metabolism related to her diagnosis of diabetes. Interventions included to administer diabetic medications per physician orders and observe for signs of hypoglycemia/ hyperglycemia. Review of November 2023 physician orders for Resident #48 revealed she had an order for lispro (a rapid acting insulin) insulin pen to administer three units subcutaneously (SQ) with meals scheduled at 7:30 A.M. and an order for insulin lispro insulin pen to be administered SQ per sliding scale including if blood sugar was 301 to 350 to administer eight units of insulin before meals and at bedtime (the morning dose was scheduled for 7:30 A.M.) Observation on 11/01/23 at 9:02 A.M. revealed Resident #48 was lying in bed when Licensed Practical Nurse (LPN)/Assistant Director of Nursing (ADON) #600 entered her room to take her blood sugar and administer her insulin. Resident #48 did not have a breakfast tray in her room. Resident #48 stated to LPN/ADON #600 that she was upset as she did not understand why LPN/ADON #600 was taking her blood sugar so late as she had already eaten her breakfast. LPN/ADON #600 took her blood sugar, and it was 306 and LPN/ADON #600 stated that Resident #48 would require sliding scale insulin coverage with her routine insulin because the blood sugar was elevated. Resident #48 stated to LPN/ADON #600 that her blood sugar would be high since she ate almost an hour ago and stated that she should not have to get coverage just because the nurse was late on checking her blood sugar. Observation on 11/01/23 at 9:17 A.M. revealed LPN/ADON #600 administered Resident #48 her routine lispro insulin three units and eight units sliding scale lispro insulin to equal 11 units to her left deltoid (arm). Interview on 11/01/23 at 9:40 A.M. with LPN/ADON #600 verified Resident #48's routine insulin was scheduled for 7:30 A.M. and her routine lispro insulin was to be administered with meals and her sliding scale lispro insulin was also scheduled for 7:30 A.M. before breakfast. She verified she obtained her blood glucose level and administered her insulin at 9:17 A.M. after she had already eaten her breakfast. Interview on 11/01/23 at 9:55 A.M. with State Tested Nursing Assistant (STNA) #601 revealed breakfast trays arrived to Resident #48's hall approximately between 7:40 A.M. and 7:50 A.M. everyday. STNA #601 passed Resident #48's breakfast tray between 7:40 A.M. to 8:00 A.M. today, 11/01/23. Interview on 11/01/23 at 10:10 A.M. with Resident #48 revealed when she was at home, she always used to take her blood sugar and administer her insulin right before she ate her meal. She revealed she was upset as frequently the nurses did not check her blood glucose level and/or give her insulin (continued on next page) FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 366267 If continuation sheet Page 4 of 7 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 366267 B. Wing A. Building (X3) DATE SURVEY COMPLETED 11/02/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Altercare of Mayfield Village, Inc 290 North Commons Blvd Mayfield Village, OH 44143 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few until after she ate. She revealed on 11/01/23 she had received her breakfast tray at approximately 8:00 A.M. and ate Cheerios and a breakfast croissant sandwich before LPN/ADON #600, had come in to check her blood sugar and administer her insulin which was after 9:00 A.M. Review of the undated facility policy labeled; Insulin Administration revealed it was the facility's policy to provide guidelines for safe administration of insulin to residents with diabetes. The policy revealed to check the blood glucose per physician order. Review of facility policy labeled, Medication Administration- General Guidelines dated May 2020 revealed medications were administered in accordance with orders of the prescriber. The nurse was to follow the five rights including right time. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 366267 If continuation sheet Page 5 of 7 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 366267 B. Wing A. Building (X3) DATE SURVEY COMPLETED 11/02/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Altercare of Mayfield Village, Inc 290 North Commons Blvd Mayfield Village, OH 44143 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0851 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Many Electronically submit to CMS complete and accurate direct care staffing information, based on payroll and other verifiable and auditable data. Based on record review and interview, the facility failed to ensure staffing data was submitted appropriately to the Centers for Medicare and Medicaid Services (CMS). This had the potential to affect all residents in the facility. The census was 36. Findings include: Review of the CMS staffing data report for quarter three of the 2023 fiscal year (from April 1 to June 30 2023) revealed the facility did not submit staffing data for the affected quarter. Interview with the Administrator on 10/31/23 at 8:37 A.M. confirmed the above findings. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 366267 If continuation sheet Page 6 of 7 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 366267 B. Wing A. Building (X3) DATE SURVEY COMPLETED 11/02/2023 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Altercare of Mayfield Village, Inc 290 North Commons Blvd Mayfield Village, OH 44143 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0947 Level of Harm - Potential for minimal harm Residents Affected - Many Ensure nurse aides have the skills they need to care for residents, and give nurse aides education in dementia care and abuse prevention. Based on interview, record review and review of facility policy the facility did not ensure State Tested Nursing Assistant (STNA) #602 received 12 hours of formal in service education within the last year. This affected one STNA out of three STNAs (#602, #604, and #605) whose personnel files were reviewed for formal education/training. This had the potential to affect 36 residents. Findings include: Review of the personnel file for STNA #602 revealed a hire date of 07/15/03. Review of STNA #602's education transcript revealed in the last 12 months STNA #604 had 0.75 total hours of training. Interview on 11/02/23 at 12:20 P.M. with Regional Staff Coordinator #603 verified STNA #602 had only completed 0.75 hours of training in the last 12 months. Review of facility policy labeled, Inservice Training dated April 2013 revealed employees must complete all assigned course work and attend mandatory in-services. The policy revealed each STNA annually must complete at least 12 hours of formal in-service education. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 366267 If continuation sheet Page 7 of 7

Reading this as a family member? Your long-term care ombudsman is a free advocate for residents and families.

Back to top

Citations

5 citations recorded*CMS

What do CMS severity letters mean?

Serious (G-L). Actual harm to a resident, or immediate jeopardy. Codes G through I indicate actual harm; J through L indicate immediate jeopardy to resident health or safety.

General (A-F). No actual harm found, or harm that is minimal. The facility must still submit a Plan of Correction. Most CMS citations land here.

Each letter combines severity with scope: how many residents the deficiency affected.

  • 0756GeneralS&S Epotential for harm

    F756 - Drug Regimen Review

    Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures.

  • 0760GeneralS&S Dpotential for harm

    F760 - Residents are free of any significant medication errors

    Ensure that residents are free from significant medication errors.

  • 0851GeneralS&S Fpotential for harm

    F851 - Mandatory submission of staffing information based on payroll data in a

    Electronically submit to CMS complete and accurate direct care staffing information, based on payroll and other verifiable and auditable data.

  • 0947GeneralS&S Cno actual harm

    F947 - Training Requirements

    Ensure nurse aides have the skills they need to care for residents, and give nurse aides education in dementia care and abuse prevention.

  • 0211GeneralS&S Fpotential for harm

    Keep aisles, corridors, and exits free of obstruction in case of emergency.

FAQ · About this visit

Common questions about this visit

What happened during the November 2, 2023 survey of ALTERCARE OF MAYFIELD VILLAGE, INC?

This was a inspection survey of ALTERCARE OF MAYFIELD VILLAGE, INC on November 2, 2023. The surveyor cited 5 deficiencies, recorded on the federal Form 2567 statement of deficiencies.

Were any deficiencies cited at ALTERCARE OF MAYFIELD VILLAGE, INC on November 2, 2023?

Yes, 5 deficiencies were cited, each with a CMS Scope and Severity grade. The first was: "Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity ..."

What type of survey was this?

This was a inspection survey conducted by state surveyors under federal Centers for Medicare & Medicaid Services (CMS) oversight. Findings are published on CMS Care Compare.

Share this reportEmail

Next steps

Concerned about a resident’s care?Find your local ombudsman through the Eldercare Locatoror file a complaint with your state survey agency.

Researching this visit professionally?Book a 15-minute calland we will walk through what we have on file.

Data from CMS Care Compare public records. Dataset last refreshed . If you believe any information is inaccurate, report it here.